Clinical Trial Update: Open-label Study to Evaluate the Efficacy and Safety of Fespixon Cream for the Treatment of Pressure Injury in Sacrum and Greater Trochanter Wound [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating Fespixon Cream for Stage 2 pressure injuries was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pressure Ulcer

Drugs mentioned

• Fespixon Cream

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Pressure Injury Stage 2 | Phase 4 | Status: TERMINATED